Collagen Peptides Market - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

Collagen peptides, also referred to as hydrolyzed collagen, have witnessed a surge in popularity within the health and wellness industry in recent years. Research indicates that the consumption of collagen peptides can enhance skin health, alleviate joint pain, and promote bone health. Consequently, consumers are increasingly recognizing the advantages of this product and integrating it into their diets. A notable trend in the market is the development of plant-based alternatives. With the growing environmental consciousness and interest in plant-based diets, these alternatives provide a sustainable and cruelty-free option compared to traditional animal-derived products. This innovative shift is anticipated to further propel market growth in the upcoming years.

Collagen Peptides Market Size 2024 to 2033

Collagen Peptides Market Overview

The Collagen Peptides market has witnessed substantial growth in recent years, propelled by the increasing recognition of collagen's multifaceted benefits in the health and wellness domain. This market overview delves into the key facets shaping the landscape of collagen peptides, exploring market dynamics, trends, and influencing factors.

Collagen Peptides Market Growth

The growth of the Collagen Peptides market is propelled by several key factors. Firstly, the global surge in health and wellness consciousness has led consumers to seek holistic solutions for maintaining overall well-being. Collagen peptides, known for their positive impact on skin health, joint support, and muscle recovery, align perfectly with this trend. The paradigm shift towards "beauty from within" has further catalyzed market expansion, as collagen peptides find widespread application in nutricosmetic formulations targeting skin, hair, and nail health. The versatility of collagen peptides in functional foods and beverages provides consumers with accessible and palatable options to incorporate these bioactive peptides into their daily diets. Scientific validation and ongoing research substantiate the health benefits of collagen peptides, instilling confidence among consumers and driving preventive healthcare practices. Despite challenges related to sourcing complexities, the Collagen Peptides market remains poised for sustained growth, offering opportunities for innovation and market expansion, particularly in emerging regions where awareness is on the rise.

Collagen Peptides Market Dynamics

Drivers

  • Health and Wellness Trends: The Collagen Peptides market is propelled by the prevailing global emphasis on health and wellness. Consumers are actively seeking products that contribute to their overall well-being, and collagen peptides, known for their various health benefits, have gained prominence in this context.
  • Beauty from Within Concept: The integration of collagen peptides into the "beauty from within" paradigm is a significant driver. With consumers increasingly prioritizing youthful skin, improved hair quality, and stronger nails, the incorporation of collagen peptides into nutricosmetic formulations has surged, driving market growth.

Restraints

  • Sourcing Complexities: A notable restraint in the Collagen Peptides market is the inherent challenge associated with sourcing high-quality collagen. The variations in sourcing, including the species and parts of animals used, can impact the consistency and quality of collagen peptides. Market players face the ongoing challenge of ensuring a secure and sustainable supply chain to maintain product integrity.
  • Product Standardization: Achieving product standardization poses a significant challenge in the Collagen Peptides market. The natural variations in collagen sources make it challenging to produce standardized products consistently. Maintaining a high level of quality and efficacy becomes crucial, requiring manufacturers to invest in advanced technologies and processes to overcome this obstacle.

Opportunities

  • Innovative Product Development: The dynamic nature of the Collagen Peptides market offers substantial opportunities for innovation. Companies investing in research and development can explore novel formulations, delivery methods, and applications for collagen peptides. Innovations in product development can cater to evolving consumer preferences and differentiate brands in a competitive market landscape.
  • Clean Label Products and Sustainable Practices: With an increasing preference for clean label products, there is an opportunity for collagen peptide manufacturers to focus on sustainability and transparent sourcing. Embracing eco-friendly practices and communicating these efforts to consumers can attract environmentally conscious buyers, contributing to brand loyalty and market growth.

The primary source of collagen peptides is the bones and cartilages of bovine animals, processed through chemical procedures to yield small-chain amino acids. Widely utilized in the food processing industry, especially in the production of confectionery like hard candies and chocolates, collagen peptides are gaining traction. The increasing efforts by companies to utilize hydrolyzed products for treating bone-related disorders, such as osteoarthritis, are expected to contribute significantly to the growth of this segment in the forecast period.

Changing lifestyles and a greater reliance on drugs and nutraceuticals for health maintenance have led to a substantial increase in consumer healthcare spending globally. Additionally, the consumption of collagen peptide supplements may aid in improving muscle-joint interaction and muscle development, making it a driving factor for increased adoption in the healthcare sector.

Microencapsulation technology stands out as another noteworthy trend, expected to enhance the stability and bioavailability of collagen peptides, thereby contributing to market growth. Moreover, the development of collagen peptide blends incorporating other functional ingredients is anticipated to further drive market expansion, meeting the rising consumer demand for products offering multiple health benefits.

Leading companies such as Rousselot, Weishardt, and GELITA AG play a pivotal role in the production of collagen peptides and end-use products for the pharmaceutical and nutraceutical sectors. Their well-established distribution networks, encompassing direct distribution for local sales and proximity sales, along with external agencies for international distribution, further strengthen their market presence.

In summary, the collagen peptides market is experiencing robust growth due to increasing health awareness, a rising demand for natural and functional ingredients, an aging population, and continuous innovation in product formulations. As the market continues to evolve, we can anticipate the introduction of more innovative products in the years to come.

Key Companies

  • FOODMATE CO. LTD. 
  • Darling Ingredients (Rousselot) 
  • Naturin Viscofan GmbH 
  • Tessenderlo Group (PB Leiner) 
  • Gelnex. 
  • GELITA AG
  •  Lapi Gelatine S.p.a.
  •  Ewald-Gelatine
  •  NITTA GELATIN  
  • Weishardt Group

Collagen Peptides Market Segmentations:

By Source Type

  • Bovine Collagen Peptides
  • Porcine Collagen Peptides
  • Marine Collagen Peptides

By Form

  • Powder
  • Liquid

By Application

  • Nutraceuticals
  • Cosmeceuticals
  • Functional Foods and Beverages

By End-Use

  • Health and Wellness
  • Pharmaceuticals

By Distribution Channel

  • Online Retail
  • Brick-and-Mortar Stores

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Collagen Peptides Market 

5.1. COVID-19 Landscape: Collagen Peptides Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Collagen Peptides Market, By Source Type

8.1. Collagen Peptides Market, by Source Type, 2024-2033

8.1.1. Bovine Collagen Peptides

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Porcine Collagen Peptides

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Marine Collagen Peptides

8.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Collagen Peptides Market, By Form

9.1. Collagen Peptides Market, by Form, 2024-2033

9.1.1. Powder

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Liquid

9.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Collagen Peptides Market, By Application 

10.1. Collagen Peptides Market, by Application, 2024-2033

10.1.1. Nutraceuticals

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Cosmeceuticals

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Functional Foods and Beverages

10.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Collagen Peptides Market, By End-Use

11.1. Collagen Peptides Market, by End-Use, 2024-2033

11.1.1. Health and Wellness

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Pharmaceuticals

11.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global Collagen Peptides Market, By Distribution Channel

12.1. Collagen Peptides Market, by Distribution Channel, 2024-2033

12.1.1. Online Retail

12.1.1.1. Market Revenue and Forecast (2021-2033)

12.1.2. Brick-and-Mortar Stores

12.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 13. Global Collagen Peptides Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Source Type (2021-2033)

13.1.2. Market Revenue and Forecast, by Form (2021-2033)

13.1.3. Market Revenue and Forecast, by Application (2021-2033)

13.1.4. Market Revenue and Forecast, by End-Use (2021-2033)

13.1.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Source Type (2021-2033)

13.1.6.2. Market Revenue and Forecast, by Form (2021-2033)

13.1.6.3. Market Revenue and Forecast, by Application (2021-2033)

13.1.6.4. Market Revenue and Forecast, by End-Use (2021-2033)

13.1.7. Market Revenue and Forecast, by Distribution Channel (2021-2033) 

13.1.8. Rest of North America

13.1.8.1. Market Revenue and Forecast, by Source Type (2021-2033)

13.1.8.2. Market Revenue and Forecast, by Form (2021-2033)

13.1.8.3. Market Revenue and Forecast, by Application (2021-2033)

13.1.8.4. Market Revenue and Forecast, by End-Use (2021-2033)

13.1.8.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Source Type (2021-2033)

13.2.2. Market Revenue and Forecast, by Form (2021-2033)

13.2.3. Market Revenue and Forecast, by Application (2021-2033)

13.2.4. Market Revenue and Forecast, by End-Use (2021-2033) 

13.2.5. Market Revenue and Forecast, by Distribution Channel (2021-2033) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Source Type (2021-2033)

13.2.6.2. Market Revenue and Forecast, by Form (2021-2033)

13.2.6.3. Market Revenue and Forecast, by Application (2021-2033)

13.2.7. Market Revenue and Forecast, by End-Use (2021-2033) 

13.2.8. Market Revenue and Forecast, by Distribution Channel (2021-2033) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Source Type (2021-2033)

13.2.9.2. Market Revenue and Forecast, by Form (2021-2033)

13.2.9.3. Market Revenue and Forecast, by Application (2021-2033)

13.2.10. Market Revenue and Forecast, by End-Use (2021-2033)

13.2.11. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Source Type (2021-2033)

13.2.12.2. Market Revenue and Forecast, by Form (2021-2033)

13.2.12.3. Market Revenue and Forecast, by Application (2021-2033)

13.2.12.4. Market Revenue and Forecast, by End-Use (2021-2033)

13.2.13. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Source Type (2021-2033)

13.2.14.2. Market Revenue and Forecast, by Form (2021-2033)

13.2.14.3. Market Revenue and Forecast, by Application (2021-2033)

13.2.14.4. Market Revenue and Forecast, by End-Use (2021-2033)

13.2.15. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Source Type (2021-2033)

13.3.2. Market Revenue and Forecast, by Form (2021-2033)

13.3.3. Market Revenue and Forecast, by Application (2021-2033)

13.3.4. Market Revenue and Forecast, by End-Use (2021-2033)

13.3.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Source Type (2021-2033)

13.3.6.2. Market Revenue and Forecast, by Form (2021-2033)

13.3.6.3. Market Revenue and Forecast, by Application (2021-2033)

13.3.6.4. Market Revenue and Forecast, by End-Use (2021-2033)

13.3.7. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Source Type (2021-2033)

13.3.8.2. Market Revenue and Forecast, by Form (2021-2033)

13.3.8.3. Market Revenue and Forecast, by Application (2021-2033)

13.3.8.4. Market Revenue and Forecast, by End-Use (2021-2033)

13.3.9. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Source Type (2021-2033)

13.3.10.2. Market Revenue and Forecast, by Form (2021-2033)

13.3.10.3. Market Revenue and Forecast, by Application (2021-2033)

13.3.10.4. Market Revenue and Forecast, by End-Use (2021-2033)

13.3.10.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Source Type (2021-2033)

13.3.11.2. Market Revenue and Forecast, by Form (2021-2033)

13.3.11.3. Market Revenue and Forecast, by Application (2021-2033)

13.3.11.4. Market Revenue and Forecast, by End-Use (2021-2033)

13.3.11.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Source Type (2021-2033)

13.4.2. Market Revenue and Forecast, by Form (2021-2033)

13.4.3. Market Revenue and Forecast, by Application (2021-2033)

13.4.4. Market Revenue and Forecast, by End-Use (2021-2033)

13.4.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Source Type (2021-2033)

13.4.6.2. Market Revenue and Forecast, by Form (2021-2033)

13.4.6.3. Market Revenue and Forecast, by Application (2021-2033)

13.4.6.4. Market Revenue and Forecast, by End-Use (2021-2033)

13.4.7. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Source Type (2021-2033)

13.4.8.2. Market Revenue and Forecast, by Form (2021-2033)

13.4.8.3. Market Revenue and Forecast, by Application (2021-2033)

13.4.8.4. Market Revenue and Forecast, by End-Use (2021-2033)

13.4.9. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Source Type (2021-2033)

13.4.10.2. Market Revenue and Forecast, by Form (2021-2033)

13.4.10.3. Market Revenue and Forecast, by Application (2021-2033)

13.4.10.4. Market Revenue and Forecast, by End-Use (2021-2033)

13.4.10.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Source Type (2021-2033)

13.4.11.2. Market Revenue and Forecast, by Form (2021-2033)

13.4.11.3. Market Revenue and Forecast, by Application (2021-2033)

13.4.11.4. Market Revenue and Forecast, by End-Use (2021-2033)

13.4.11.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Source Type (2021-2033)

13.5.2. Market Revenue and Forecast, by Form (2021-2033)

13.5.3. Market Revenue and Forecast, by Application (2021-2033)

13.5.4. Market Revenue and Forecast, by End-Use (2021-2033)

13.5.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Source Type (2021-2033)

13.5.6.2. Market Revenue and Forecast, by Form (2021-2033)

13.5.6.3. Market Revenue and Forecast, by Application (2021-2033)

13.5.6.4. Market Revenue and Forecast, by End-Use (2021-2033)

13.5.7. Market Revenue and Forecast, by Distribution Channel (2021-2033)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Source Type (2021-2033)

13.5.8.2. Market Revenue and Forecast, by Form (2021-2033)

13.5.8.3. Market Revenue and Forecast, by Application (2021-2033)

13.5.8.4. Market Revenue and Forecast, by End-Use (2021-2033)

13.5.8.5. Market Revenue and Forecast, by Distribution Channel (2021-2033)

Chapter 14. Company Profiles

14.1. FOODMATE CO. LTD.

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Darling Ingredients (Rousselot)

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Naturin Viscofan GmbH

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Tessenderlo Group (PB Leiner)

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Gelnex

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. GELITA AG

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Lapi Gelatine S.p.a.

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Ewald-Gelatine

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. NITTA GELATIN 

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Weishardt Group

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers